Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! 

China Clinical Trials 2017

Analysis of IND and NDA applications and approvals in China 2011-2017

Download free report on life science investment in China

China Nepstar Pharmacy Chain Files for IPO

publication date: Oct 18, 2007
China Nepstar, the largest drugstore chain in China, filed to make its IPO on the NYSE, seeking to raise up to $250 million. China Nepstar is growing fast, with a CAGR of 43.4% from 2004 to 2006. It now operates 1,791 stores in 62 cities, up from 668 stores in 2004. Although Nepstar is the biggest chain in China, it represents less than .5% of all the retail non-hospital pharmacies. More details...

Stock Symbols: (NYSE: NPD)

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China